Cite
HARVARD Citation
Fernandez-Penas, P. et al. (n.d.). 799 Durable responses and immune activation with intratumoral electroporation of pIL-12 plus pembrolizumab in actively progressing anti-PD-1 refractory advanced melanoma: KEYNOTE 695 interim data. Journal for immunotherapy of cancer. pp. A477-A478. [Online].